Live Breaking News & Updates on Ecaterina Dumbrava

Stay updated with breaking news from Ecaterina dumbrava. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SOTIO Biotech: SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting

Patient enrollment and dosing ongoing in first-in-human study of BOXR1030 enhanced CAR T-cell therapy SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, will present ....

United States , Ecaterina Dumbrava , Lisa Raffensperger , Richard Kapsa , University Of Texas Md Anderson Cancer Center , American Society Of Clinical Oncology , Clinical Oncology , Assistant Professor , Investigational Cancer Therapeutics , Cancer Center , Ihr Portfolio ,

SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting

SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Ecaterina Dumbrava , American Society Of Clinical Oncology , University Of Texas Md Anderson Cancer Center , Product Service , Clinical Oncology , Assistant Professor , Investigational Cancer Therapeutics , Cancer Center ,

Compugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity in Patients Typically Not Responding to Immunotherapy

Compugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity in Patients Typically Not Responding to Immunotherapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University Of Texas , United States , San Francisco , Israel General , Tel Aviv , Yvonne Naughton , Gady Cojocaru , Ecaterina Dumbrava , Stephanie Gaillard , Securities Exchange , Corporate Communications , Exchange Commission , Compugen Ltd , Stock Exchange , Anderson Cancer Center , Annual Meeting , Hopkins Sidney Kimmel Comprehensive Cancer Center , Looking Statement , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Investor Relations ,

PMV's ASCO data show signs of drugging 'undruggable' p53 protein across tumor types

PMV Pharmaceuticals has its first clinical data showing that its lead therapeutic candidate can hit p53, a tumor-suppressing protein long thought to be undruggable. After reporting the preliminary data during ASCO, PMV said it plans to continue Phase 1 study with the goal of advancing to Phase 2 early next year. ....

United States , Israel General , Comunidad Autonoma De Cataluna , Irene Brana , Leila Alland , American Society Of Clinical Oncology , Hebron Institute Of Oncology , Md Anderson Cancer Center Ecaterina Dumbrava , Atrin Pharmaceuticals , American Society , Cancer Center , Ecaterina Dumbrava , New Jersey Based , Hebron Institute , Aprea Therapeutics , Medical Officer Leila Alland , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding ,